Suppr超能文献

鉴定干扰 H1N1 甲型流感病毒复制的小分子。

Identification of small molecules that interfere with H1N1 influenza A viral replication.

机构信息

Infectious and Inflammatory Disease Center (IIDC) and Cancer Center (CC), Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

ChemMedChem. 2012 Dec;7(12):2227-35. doi: 10.1002/cmdc.201200453. Epub 2012 Nov 8.

Abstract

Successful replication of the influenza A virus requires both viral proteins and host cellular factors. In this study we used a cellular assay to screen for small molecules capable of interfering with any of such necessary viral or cellular components. We used an established reporter assay to assess influenza viral replication by monitoring the activity of co-expressed luciferase. We screened a diverse chemical compound library, resulting in the identification of compound 7, which inhibits a novel yet elusive target. Quantitative real-time PCR studies confirmed the dose-dependent inhibitory activity of compound 7 in a viral replication assay. Furthermore, we showed that compound 7 is effective in rescuing high-dose influenza infection in an in vivo mouse model. As oseltamivir-resistant influenza strains emerge, compound 7 could be further investigated as a new and potentially suitable scaffold for the development of anti-influenza agents that act on novel targets.

摘要

成功复制流感病毒需要病毒蛋白和宿主细胞因子。在这项研究中,我们使用细胞测定法筛选能够干扰任何必要病毒或细胞成分的小分子。我们使用已建立的报告基因测定法通过监测共表达的荧光素酶的活性来评估流感病毒的复制。我们筛选了多种化学化合物文库,结果鉴定出了化合物 7,它可抑制一种新颖但难以捉摸的靶标。实时定量 PCR 研究证实了化合物 7 在病毒复制测定中具有剂量依赖性的抑制活性。此外,我们表明化合物 7在体内小鼠模型中对高剂量流感感染具有有效的挽救作用。随着耐奥司他韦的流感病毒株的出现,化合物 7 可以进一步作为开发针对新型靶标的抗流感药物的新型和潜在合适的支架进行研究。

相似文献

1
Identification of small molecules that interfere with H1N1 influenza A viral replication.
ChemMedChem. 2012 Dec;7(12):2227-35. doi: 10.1002/cmdc.201200453. Epub 2012 Nov 8.
2
Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Antiviral Res. 2016 Mar;127:68-78. doi: 10.1016/j.antiviral.2016.01.011. Epub 2016 Jan 21.
5
Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.
Antimicrob Agents Chemother. 2011 Dec;55(12):5553-9. doi: 10.1128/AAC.00725-11. Epub 2011 Sep 19.
6
7
Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
J Virol. 2019 Aug 13;93(17). doi: 10.1128/JVI.00878-19. Print 2019 Sep 1.
8
Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.
J Cell Mol Med. 2018 Mar;22(3):1826-1839. doi: 10.1111/jcmm.13467. Epub 2017 Nov 30.
9
Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Antiviral Res. 2017 Jul;143:106-112. doi: 10.1016/j.antiviral.2017.02.010. Epub 2017 Feb 21.

引用本文的文献

1
High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assay.
Antiviral Res. 2025 Aug;240:106209. doi: 10.1016/j.antiviral.2025.106209. Epub 2025 Jun 6.
2
High-Throughput cell-based immunofluorescence assays against influenza.
SLAS Discov. 2024 Jan;29(1):66-76. doi: 10.1016/j.slasd.2023.10.008. Epub 2023 Nov 2.
3
Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus.
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0024421. doi: 10.1128/AAC.00244-21.
4
miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.
Arch Virol. 2021 Feb;166(2):363-373. doi: 10.1007/s00705-020-04877-z. Epub 2020 Nov 18.
5
Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
Viruses. 2019 Feb 22;11(2):190. doi: 10.3390/v11020190.
6
Development and applications of single-cycle infectious influenza A virus (sciIAV).
Virus Res. 2016 May 2;216:26-40. doi: 10.1016/j.virusres.2015.07.013. Epub 2015 Jul 26.
7
Targeting Influenza A Virus RNA Promoter.
Chem Biol Drug Des. 2015 Oct;86(4):663-73. doi: 10.1111/cbdd.12534. Epub 2015 Mar 13.
8
New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.
Antiviral Res. 2013 Oct;100(1):120-32. doi: 10.1016/j.antiviral.2013.07.018. Epub 2013 Aug 6.

本文引用的文献

2
Cellular networks involved in the influenza virus life cycle.
Cell Host Microbe. 2010 Jun 25;7(6):427-39. doi: 10.1016/j.chom.2010.05.008.
3
Human host factors required for influenza virus replication.
Nature. 2010 Feb 11;463(7282):813-7. doi: 10.1038/nature08699.
4
Emerging antiviral targets for influenza A virus.
Trends Pharmacol Sci. 2009 Jun;30(6):269-77. doi: 10.1016/j.tips.2009.03.002. Epub 2009 May 8.
5
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
Pigment Cell Melanoma Res. 2009 Apr;22(2):187-95. doi: 10.1111/j.1755-148X.2009.00544.x. Epub 2009 Jan 17.
6
CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.
Antimicrob Agents Chemother. 2009 Jan;53(1):186-92. doi: 10.1128/AAC.00333-08. Epub 2008 Oct 27.
7
Structure and mechanism of the M2 proton channel of influenza A virus.
Nature. 2008 Jan 31;451(7178):591-5. doi: 10.1038/nature06531.
8
Derivation, characterization, and in vitro differentiation of canine embryonic stem cells.
Stem Cells. 2008 Feb;26(2):465-73. doi: 10.1634/stemcells.2007-0640. Epub 2007 Dec 6.
9
The significance of p53 and retinoblastoma pathways in canine hemangiosarcoma.
J Vet Med Sci. 2007 Mar;69(3):271-8. doi: 10.1292/jvms.69.271.
10
Endocytosis of influenza viruses.
Microbes Infect. 2004 Aug;6(10):929-36. doi: 10.1016/j.micinf.2004.05.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验